This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.
Study Type
OBSERVATIONAL
Enrollment
400
Participants will take a high-sensitivity urine pregnancy test at home weekly for up to 4 weeks compared to the taking just one home urine pregnancy test at 4-5 weeks. Participants will also complete short weekly questionnaires on their pregnancy symptoms and follow-up care.
Carafem
Atlanta, Georgia, United States
RECRUITINGCarafem
Chevy Chase, Maryland, United States
RECRUITINGCedar River Clinics
Renton, Washington, United States
RECRUITINGProportion of participants with negative high-sensitivity urine pregnancy test at 2 weeks
To estimate the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 2 weeks after taking Mifepristone and compare this proportion to the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 4 weeks
Time frame: From time of taking Mifepristone to negative pregnancy test or 4-5 weeks of questionnaires
Time to resolution of pregnancy symptoms
To compare the timing of pregnancy symptom resolution per patient report on weekly questionnaires with the timing of a negative high-sensitivity urine pregnancy test result
Time frame: From time of taking Mifepristone to negative pregnancy test or 4-5 weeks of questionnaires
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.